Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-025878
Filing Date
2021-02-19
Accepted
2021-02-19 19:35:38
Documents
1
Period of Report
2021-02-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm217124-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm217124-2_4seq1.xml 4 20255
  Complete submission text file 0001104659-21-025878.txt   21582
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
O'Neill Vincent (Reporting) CIK: 0001672718 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 21657839

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations